Our findings suggest that MeCP2 interacts with SPI1 and delivers it to the ZEB1 promoter, resulting in transcriptional activation of ZEB1, and subsequent upregulation of downstream target genes involved in tumor cell metastasis and stemness. The gene discussed is SPI1; the disease is neoplasm.